Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05335070 · ClinicalTrials.gov registry record · Phase 2

Reducing Pain From Wisdom Molar Extractions

A Phase 2 study of Acute Pain, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
Phase 2
Development phase
20
Enrollment target
1
Study location

NCT05335070 is a Phase 2 study of Acute Pain that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 20 participants, below the 268-participant average among 50 other Acute Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05335070, a Phase 2 study of Acute Pain, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
Phase 2
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study evaluating the ability of the Temporo-masseteric Nerve Block local anesthetic injection (this was called the Twin Block earlier) to reduce pain experienced by individuals undergoing removal of lower third molar(s) under intravenous sedation. Study participants will be queried for pain experience and pain medications taken during the first post-operative week and will present for a follow-up visit on Day 8.

Conditions Studied

Interventions

  • DRUG Temporo-masseteric Nerve Block

Study Locations (1)

New Jersey

  • The University Hospital- Dental Clinic - Newark

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-09-13
Est. Completion 2026-12
Phase Phase 2

What the Registry Record Tells You About NCT05335070

The ClinicalTrials.gov registry entry for NCT05335070 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 50 other Acute Pain trials with a reported enrollment target (93% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 1 intervention - of which Temporo-masseteric Nerve Block is the first listed.

NCT05335070 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05335070 about?

NCT05335070 is a clinical study titled "Reducing Pain From Wisdom Molar Extractions". This is a pilot study evaluating the ability of the Temporo-masseteric Nerve Block local anesthetic injection (this was called the Twin Block earlier) to reduce pain experienced by individuals undergoing removal of lower third molar(s) under intravenous sedation. Study participants will be queried f...

What is the current status of trial NCT05335070?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2022-09-13. Estimated completion is 2026-12.

What conditions does trial NCT05335070 study?

This clinical trial studies the following conditions: Acute Pain.

What interventions are being tested in trial NCT05335070?

The interventions under investigation include: Temporo-masseteric Nerve Block (DRUG).

Who is sponsoring clinical trial NCT05335070?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05335070 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.